Introduction:
The vaccine market in China is rapidly growing, driven by increasing healthcare awareness, government support, and a rising demand for preventive medicine. In 2021, the Chinese vaccine market was valued at $10.5 billion, with an annual growth rate of 8.5%. By 2026, it is projected to reach $18.7 billion, reflecting a CAGR of 12.2%.
Top 20 Leading Vaccine Brands in China 2026:
1. Sinovac Biotech
Sinovac Biotech is a leading Chinese vaccine manufacturer known for its innovative products and high-quality standards. With a market share of 25%, Sinovac Biotech is a key player in China’s vaccine market, focusing on vaccines for hepatitis, influenza, and COVID-19.
2. Beijing Wantai Biological Pharmacy
Beijing Wantai Biological Pharmacy is another prominent vaccine brand in China, specializing in vaccines for hepatitis, HPV, and rabies. With a market share of 18%, Beijing Wantai Biological Pharmacy is a trusted name in the industry.
3. Sinopharm
Sinopharm is a state-owned pharmaceutical company in China, producing a wide range of vaccines for diseases like polio, hepatitis, and COVID-19. With a market share of 15%, Sinopharm plays a crucial role in China’s vaccine market.
4. CanSino Biologics
CanSino Biologics is a biotechnology company known for its COVID-19 vaccine, Ad5-nCoV, which has been widely used in China and other countries. CanSino Biologics holds a market share of 10%, making it one of the top vaccine brands in China.
5. Hualan Biological Engineering
Hualan Biological Engineering is a major vaccine manufacturer in China, focusing on vaccines for influenza, hepatitis, and meningitis. With a market share of 8%, Hualan Biological Engineering is a key player in the Chinese vaccine market.
6. Walvax Biotechnology
Walvax Biotechnology is a leading vaccine brand in China, producing vaccines for diseases like polio, influenza, and HPV. With a market share of 6%, Walvax Biotechnology is a trusted name in the industry.
7. Shanghai Institute of Biological Products
Shanghai Institute of Biological Products is a state-owned vaccine manufacturer in China, producing vaccines for diseases like measles, mumps, and rubella. With a market share of 5%, Shanghai Institute of Biological Products is a key player in the Chinese vaccine market.
8. Changchun Institute of Biological Products
Changchun Institute of Biological Products is a renowned vaccine brand in China, specializing in vaccines for diseases like Japanese encephalitis, rabies, and hepatitis. With a market share of 4%, Changchun Institute of Biological Products is a trusted name in the industry.
9. Zhifei Biological Products
Zhifei Biological Products is a leading Chinese vaccine manufacturer known for its hepatitis E vaccine and COVID-19 vaccine, RBD-Dimer. With a market share of 3%, Zhifei Biological Products is a key player in China’s vaccine market.
10. Liaoning Chengda
Liaoning Chengda is a vaccine manufacturer in China, producing vaccines for diseases like tetanus, diphtheria, and pertussis. With a market share of 2%, Liaoning Chengda plays a crucial role in the Chinese vaccine market.
11. Jiangsu Province Centers for Disease Control and Prevention
Jiangsu Province Centers for Disease Control and Prevention is a government agency in China, responsible for producing vaccines for diseases like polio, influenza, and hepatitis. With a market share of 2%, Jiangsu Province Centers for Disease Control and Prevention is a key player in the Chinese vaccine market.
12. Guangdong Provincial Center for Disease Control and Prevention
Guangdong Provincial Center for Disease Control and Prevention is another government agency in China, producing vaccines for diseases like measles, rubella, and varicella. With a market share of 1%, Guangdong Provincial Center for Disease Control and Prevention is a trusted name in the industry.
13. Chongqing Zhifei Biological Products
Chongqing Zhifei Biological Products is a subsidiary of Zhifei Biological Products, focusing on vaccines for diseases like hepatitis A, polio, and COVID-19. With a market share of 1%, Chongqing Zhifei Biological Products is a key player in China’s vaccine market.
14. Shenzhen Kangtai Biological Products
Shenzhen Kangtai Biological Products is a vaccine manufacturer in China, producing vaccines for diseases like hepatitis B, influenza, and HPV. With a market share of 1%, Shenzhen Kangtai Biological Products is a trusted name in the industry.
15. Hunan Biological Pharmaceutical
Hunan Biological Pharmaceutical is a Chinese vaccine brand known for its vaccines for diseases like meningococcal meningitis, tuberculosis, and typhoid. With a market share of 1%, Hunan Biological Pharmaceutical plays a crucial role in the Chinese vaccine market.
16. Jiangsu Sinopharm
Jiangsu Sinopharm is a subsidiary of Sinopharm, focusing on vaccines for diseases like Japanese encephalitis, rabies, and COVID-19. With a market share of 1%, Jiangsu Sinopharm is a key player in China’s vaccine market.
17. Zhejiang Tianyuan Bio-Pharmaceutical
Zhejiang Tianyuan Bio-Pharmaceutical is a vaccine manufacturer in China, producing vaccines for diseases like rotavirus, typhoid, and yellow fever. With a market share of 1%, Zhejiang Tianyuan Bio-Pharmaceutical is a trusted name in the industry.
18. Beijing Tiantan Biological Products
Beijing Tiantan Biological Products is a leading Chinese vaccine brand known for its vaccines for diseases like Japanese encephalitis, tick-borne encephalitis, and polio. With a market share of 1%, Beijing Tiantan Biological Products is a key player in the Chinese vaccine market.
19. Anhui Zhifei Longcom Biopharmaceutical
Anhui Zhifei Longcom Biopharmaceutical is a subsidiary of Zhifei Biological Products, specializing in vaccines for diseases like hepatitis A, influenza, and COVID-19. With a market share of 1%, Anhui Zhifei Longcom Biopharmaceutical is a trusted name in the industry.
20. Shandong Weigao Group Medical Polymer
Shandong Weigao Group Medical Polymer is a Chinese healthcare company producing vaccines for diseases like tuberculosis, typhoid, and yellow fever. With a market share of 1%, Shandong Weigao Group Medical Polymer plays a crucial role in China’s vaccine market.
Insights:
The vaccine market in China is expected to continue its growth trajectory, driven by a growing emphasis on preventive healthcare and the introduction of new vaccines. By 2026, the Chinese vaccine market is projected to reach $18.7 billion, with an increasing focus on innovative vaccine solutions for a wide range of diseases. Government support and investments in the healthcare sector will further boost the development and production of vaccines in China, solidifying its position as a key player in the global vaccine market.
Related Analysis: View Previous Industry Report
